Camlin Fine Sciences Limited is an India-based company, which is engaged in the research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company’s products are categorized into shelf-life solutions, performance chemicals, aroma ingredients, and health and wellness. Its products include catechol, tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), Ascorbyl Palmitate (ASP), 4-Tertiary Butyl Catechol, Xtendra, Guaiacol, Para DiMethoxy Benzene, NaSure, Hydroquinone, and Veratrole. Its aroma ingredients mainly include Vanillin, Ethyl Vanillin, and Natural Vanillin. The Company’s products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances, and health care. Its brands include Ezential, Nasure, adorr, Dinamics, Xtendra, and Biosis.As of 27 May 2026, Camlin Fine Sciences share price is ₹130.19. The stock opened at ₹120.99, compared to its previous close of ₹121.56. During today's trading session, Camlin Fine Sciences share price moved in the range of ₹119.84 to ₹131.78, with an average price of ₹125.81 for the day. Looking at its last 52-week, the stock has touched a low of ₹119.84 and a high of ₹131.78. On the performance front, Camlin Fine Sciences share price has declined by 23.32% over the last six months and is down 44.11% on a year-on-year basis.
The market capitalization of Camlin Fine Sciences is ₹2,332 Crs, with a P/E ratio of -37.2 and a dividend yield of 0.00%.